Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yinan Linuo Pharmaceutical is a Chinese pharmaceutical manufacturing company and a key subsidiary of the Linuo Group, based in Yinan County, Shandong Province. The company focuses on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly for cardiovascular, respiratory, and metabolic conditions. Operating with modern, GMP-certified facilities, it serves as a major production base for the Linuo Pharmaceutical division, supplying both the domestic Chinese market and international clients. Its product portfolio includes widely used generic medications such as Gliclazide for diabetes and Trimetazidine for heart conditions. The company integrates advanced chemical synthesis with formulation expertise to maintain a competitive position in the global generics market. Yinan Linuo Pharmaceutical is committed to high quality standards and plays a vital role in the Linuo Group's broader healthcare and life sciences strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yinan Linuo Pharmaceutical.